Our peer-reviewed study in JMIR Formative Research found that active subscribers on the semaglutide-supported programme lost an average of 19.1% of their body weight at 12 months, with 77.7% achieving at least 10% weight loss
More than 4 days past missed dose: Skip it
GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide) and the dual agonist tirzepatide are backed by STEP ( The New England Journal of Medicine , 2021), SURMOUNT (NEJM, 2022), and SURMOUNT-OSA (NEJM, 2024)
Understanding when tirzepatide begins to produce measurable effects requires distinguishing between its impact on blood glucose levels and weight loss, as these outcomes follow different timelines
For those without insurance or opting for self-pay, affordable pricing options start at $99 for initial consultations
The pooled mean difference (diamond apex) and 95% CI (diamond width) are calculated using a random effects model